Cleveland-based MetroHealth System recorded operating income of $63 million (5.5% operating margin) in the first half of 2026, up from an operating loss of $13.9 million (-1.4% margin) during the same period last year, according to its financial report for the six months ended June 30.
Four things to know:
1. MetroHealth reported total operating revenue of $1.2 billion for the first half of 2026, a 12.6% increase year over year. Net patient service revenue rose 16.6% year over year to $824.5 million. Other revenue increased 3.6% to $327.7 million.
2. Total operating expenses were $1.1 billion for the six-month period, a 5% increase year over year. Salaries and wages totaled $473.5 million, a 3% increase year over year, while employee benefits rose 7% to $138.7 million. Pharmaceutical expenses increased 10.4% to $185.9 million, and other expenses rose 46.3% to $60.8 million. Purchased services expenses declined 12.7% to $69.2 million.
3. Discharges at the medical center increased 4.9% year over year to 13,573, while patient days declined 2.3% to 75,462. Average length of stay fell to 5.6 days from 6 days a year earlier. Systemwide, emergency visits declined 5.3% to 74,022, and total outpatient visits fell 1.7% to 702,248.
4. MetroHealth reported net income of $65.6 million in the first half of 2026, compared with a net loss of $11 million during the same period last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
